| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.6 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |